Press release
PREMIER Biosoft and MRC-Holland form an alliance
PREMIER Biosoft International, a leading bioinformatics company, and MRC-Holland, the inventors of MLPA® technology, announced an alliance. Multiplex Ligation-dependent Probe Amplification (MLPA®) is a method to establish the copy number of up to 45 nucleic acid sequences in a single reaction. Detecting copy number changes in the genome, the primary application of MLPA® technology, is a widely researched area. Current efforts are directed towards more comprehensive cataloging and characterization of these changes. MLPA® probes are able to discriminate between sequences that differ by just one nucleotide, making them a highly sensitive and precise tool for detecting the changes. It is rapidly becoming the most favored among the currently used methods.The alliance will help MLPA® users design custom oligos for genes that do not have kits available. Currently, no such design tool exists. "With this collaboration, both PREMIER Biosoft and MRC-Holland will use their core competencies and expertise to develop a powerful bioinformatics tool for MLPA® users." commented Kay Brown, V.P. Business Development and Marketing.
About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting-edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Additional information about PREMIER Biosoft International is available at http://www.PremierBiosoft.com
About MRC-Holland
MRC-Holland published its first article about MLPA® technology in 2002 and since then, its product range has grown explosively. The company now offers well over a 100 different MLPA® tests for a wide range of applications, from rare genetic diseases to tumor analysis. MRC-Holland aims to make the MLPA® technology available to all scientists and works in close collaboration with researchers around the world. More information about MRC-Holland can be found on www.MLPA.com.
Contact:
Arun Apte
PREMIER Biosoft International
650-856-2703
http://www.PremierBiosoft.com
PREMIER Biosoft International
Founded in 1994, is a group of computer scientists and molecular biologists dedicated to producing cutting edge intuitive software for the molecular biologist. Our goal is to study the most recent innovations in molecular biology and translate them into software products that aid the biologist.
PREMIER Biosoft International
3786 Corina Way
Palo Alto, CA 94303-4504
Phone:650-856-2703
Fax: 650-618-1773
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PREMIER Biosoft and MRC-Holland form an alliance here
News-ID: 14035 • Views: …
More Releases for MLPA
Nephro Genetic Testing Market Outlook 2022- Explains COVID-19 Impact, Share and …
Global Nephro Genetic Testing Market Report provides Market Size, Trends, forecast period with analysis of the market's historic and forecast growth, drivers and restraints affecting the market, and highlights of the opportunities that companies in the industry can take on. The Nephro Genetic Testing research report examines the approach line of business. Also, the research survey studies market activities like drivers, new possibilities, insight, obstacles.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5609636
Top…
Commensuration With Innovative Pace To Take The Cardiovascular Genomic Diagnosti …
The global Cardiovascular Genomic Diagnostics Market is on the verge of witnessing a drastic In Upcoming Years. The digital renaissance is dictating the terms for the industry. AI-powered data core is being used for delivering insights. Also, the virtual workforce is being developed with a transfer of digital skills, that too, from a plethora of innovative ecosystems and industries. Conversational AI is being deployed for helping the end-users with timely…
Global Hematology Probes Market Trends, Size, Competitive Analysis and Forecast …
The global hematology probes market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The growing research related to the genome coupled with the advancements in the biotechnology vertical has paved numerous opportunities for market growth. Some other major factors which primarily include the rising prevalence of blood disorders along with the rising awareness about such disorders and the presence of sophisticated & advanced technologies are…
Global Chromosome Enumeration Probes (CEP) Market Top Leading Players with Strat …
The global chromosome enumeration probes (CEP) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The continuous growing prevalence of target disorders, the rising investments in in-vitro diagnostics space, coupled with the technological advancements in in-situ hybridization (ISH) are a few of the pivotal factors driving the market growth. Another key factor driving the market growth includes the key role of CEPs in many applications,…
What's Happening With Cardiovascular genomic diagnostics market? Color Genomics, …
Heart related disorders are mostly inherited from parents to their children. Cardiovascular genomic di-agnostics testing helps in detecting these inherited diseases such as cardiac channelopathies and con-genital heart diseases. Besides cardiovascular genomic diagnostics can also be helpful for family members who have risks of developing heart problems. These genetic disorders affect by impairing development of blood vessels which leads to onset of heart diseases. Therefore, cardiovascular genomic diagnostics help in…
PREMIER Biosoft International releases AlleleID version 7.01 offering enhanced s …
Palo Alto, California – March 5, 2009 PREMIER Biosoft International today announced the world wide release of AlleleID version 7.01. AlleleID, the suite for qPCR and microarrays, now includes support for the latest design guidelines laid down by MRC-Holland, the inventors of the technology. MLPA® is an easy-to-use molecular biology technique which has been gaining attention especially for studies of DNA copy number changes.
With this release, AlleleID now also…
